Cancer Research Cancer Epigenetics Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kunkel, P.
Right arrow Articles by Lamszus, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunkel, P.
Right arrow Articles by Lamszus, K.
[Cancer Research 61, 6624-6628, September 15, 2001]
© 2001 American Association for Cancer Research

Advances in Brief

Inhibition of Glioma Angiogenesis and Growth in Vivo by Systemic Treatment with a Monoclonal Antibody against Vascular Endothelial Growth Factor Receptor-21

Philip Kunkel, Ulrike Ulbricht, Peter Bohlen, Marc A. Brockmann, Regina Fillbrandt, Dimitrios Stavrou, Manfred Westphal and Katrin Lamszus2

Departments of Neurosurgery [P. K., U. U., M. A. B., R. F., M. W.] and Neuropathology [D. S., K. L.], University Hospital Hamburg-Eppendorf, 20246 Hamburg, Germany, and ImClone Systems, Inc. [P. B.], New York, New York 10014

Using an orthotopic intracerebral model, we investigated whether systemic treatment with DC101, a monoclonal antibody against vascular endothelial growth factor receptor (VEGFR)-2, could inhibit angiogenesis and the growth of human glioblastoma cells in severe combined immunodeficient mice. Intraperitoneal treatment with DC101, control IgG, or PBS was initiated either on day 0 or, in another series, on day 6 after tumor cell implantation, and animals were killed ~2 weeks after tumor cell injection. Tumor volumes in animals treated with DC101 were reduced by 59 and 81% compared with IgG and PBS controls, respectively (P < 0.001), when treatment was initiated immediately, and similar results were obtained when treatment started on day 6. Microvessel density in tumors of DC101-treated animals was reduced by at least 40% compared with animals treated with control IgG or PBS (P < 0.01). We observed a reduction in tumor cell proliferation and an increase in apoptosis in DC101-treated animals (P < 0.001). However, in mice treated with DC101, we also noticed a striking increase in the number and total area of small satellite tumors clustered around, but distinct from, the primary. These satellites usually contained central vessel cores, and tumor cells often had migrated over long distances along the host vasculature to eventually reach the surface and spread leptomeningeally. We conclude that systemic antagonization of VEGFR-2 can inhibit glioblastoma neovascularization and growth but can lead to increased cooption of preexistent cerebral blood vessels. Therefore, a combination of different treatment modalities which also include anti-invasive therapy may be needed for an effective therapy against glioblastoma, and the use of an antibody against VEGFR-2 may be one effective component.




This article has been cited by other articles:


Home page
 NeurologyHome page
F. M. Iwamoto, L. E. Abrey, K. Beal, P. H. Gutin, M. K. Rosenblum, V. E. Reuter, L. M. DeAngelis, and A. B. Lassman
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
Neurology, October 13, 2009; 73(15): 1200 - 1206.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. M. Conn, K. A. Botkjaer, T. A. Kupriyanova, P. A. Andreasen, E. I. Deryugina, and J. P. Quigley
Comparative Analysis of Metastasis Variants Derived from Human Prostate Carcinoma Cells: Roles in Intravasation of VEGF-Mediated Angiogenesis and uPA-Mediated Invasion
Am. J. Pathol., October 1, 2009; 175(4): 1638 - 1652.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. M. L. Ebos, C. R. Lee, and R. S. Kerbel
Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy
Clin. Cancer Res., August 15, 2009; 15(16): 5020 - 5025.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. K. Lucio-Eterovic, Y. Piao, and J. F. de Groot
Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy
Clin. Cancer Res., July 15, 2009; 15(14): 4589 - 4599.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. L. Bearer, J. S. Lowengrub, H. B. Frieboes, Y.-L. Chuang, F. Jin, S. M. Wise, M. Ferrari, D. B. Agus, and V. Cristini
Multiparameter Computational Modeling of Tumor Invasion
Cancer Res., May 15, 2009; 69(10): 4493 - 4501.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Taillibert, L. A. Vincent, B. Granger, Y. Marie, C. Carpentier, R. Guillevin, A. Bellanger, K. Mokhtari, A. Rousseau, D. Psimaras, et al.
Bevacizumab and irinotecan for recurrent oligodendroglial tumors
Neurology, May 5, 2009; 72(18): 1601 - 1606.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
Q. Zhou and J. M. Gallo
Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model
Neuro-oncol, January 1, 2009; 11(3): 301 - 310.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
E. C. Quant, A. D. Norden, J. Drappatz, A. Muzikansky, L. Doherty, D. LaFrankie, A. Ciampa, S. Kesari, and P. Y. Wen
Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab
Neuro-oncol, January 1, 2009; 11(5): 550 - 555.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Martens, Y. Laabs, H. S. Gunther, D. Kemming, Z. Zhu, L. Witte, C. Hagel, M. Westphal, and K. Lamszus
Inhibition of Glioblastoma Growth in a Highly Invasive Nude Mouse Model Can Be Achieved by Targeting Epidermal Growth Factor Receptor but not Vascular Endothelial Growth Factor Receptor-2
Clin. Cancer Res., September 1, 2008; 14(17): 5447 - 5458.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. D. Norden, G. S. Young, K. Setayesh, A. Muzikansky, R. Klufas, G. L. Ross, A. S. Ciampa, L. G. Ebbeling, B. Levy, J. Drappatz, et al.
Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
Neurology, March 4, 2008; 70(10): 779 - 787.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
S. Kesari, D. Schiff, J. W. Henson, A. Muzikansky, D. C. Gigas, L. Doherty, T. T. Batchelor, J. A. Longtine, K. L. Ligon, S. Weaver, et al.
Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults
Neuro-oncol, January 1, 2008; 10(3): 300 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
C. Gomez-Manzano, J. Holash, J. Fueyo, J. Xu, C. A. Conrad, K. D. Aldape, J. F. de Groot, B. N. Bekele, and W. K. A. Yung
VEGF Trap induces antiglioma effect at different stages of disease
Neuro-oncol, January 1, 2008; 10(6): 940 - 945.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. Claes, P. Wesseling, J. Jeuken, C. Maass, A. Heerschap, and W. P.J. Leenders
Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization
Mol. Cancer Ther., January 1, 2008; 7(1): 71 - 78.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
S. de Bouard, P. Herlin, J. G. Christensen, E. Lemoisson, P. Gauduchon, E. Raymond, and J.-S. Guillamo
Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma
Neuro-oncol, October 1, 2007; 9(4): 412 - 423.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
S. Kesari, D. Schiff, L. Doherty, D. C. Gigas, T. T. Batchelor, A. Muzikansky, A. O'Neill, J. Drappatz, A. S. Chen-Plotkin, N. Ramakrishna, et al.
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults
Neuro-oncol, July 1, 2007; 9(3): 354 - 363.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. O. Sakariassen, L. Prestegarden, J. Wang, K.-O. Skaftnesmo, R. Mahesparan, C. Molthoff, P. Sminia, E. Sundlisaeter, A. Misra, B. B. Tysnes, et al.
Angiogenesis-independent tumor growth mediated by stem-like cancer cells
PNAS, October 31, 2006; 103(44): 16466 - 16471.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Martens, N.-O. Schmidt, C. Eckerich, R. Fillbrandt, M. Merchant, R. Schwall, M. Westphal, and K. Lamszus
A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo.
Clin. Cancer Res., October 15, 2006; 12(20): 6144 - 6152.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Sathornsumetee, A. B. Hjelmeland, S. T. Keir, R. E. McLendon, D. Batt, T. Ramsey, N. Yusuff, B.K. A. Rasheed, M. W. Kieran, A. Laforme, et al.
AAL881, a Novel Small Molecule Inhibitor of RAF and Vascular Endothelial Growth Factor Receptor Activities, Blocks the Growth of Malignant Glioma.
Cancer Res., September 1, 2006; 66(17): 8722 - 8730.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
T. Troiani, O. Lockerbie, M. Morrow, F. Ciardiello, and S. G. Eckhardt
Sequence-dependent inhibition of human colon cancer cell growth and of prosurvival pathways by oxaliplatin in combination with ZD6474 (Zactima), an inhibitor of VEGFR and EGFR tyrosine kinases.
Mol. Cancer Ther., July 1, 2006; 5(7): 1883 - 1894.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
V. Cristini, H. B. Frieboes, R. Gatenby, S. Caserta, M. Ferrari, and J. Sinek
Morphologic Instability and Cancer Invasion
Clin. Cancer Res., October 1, 2005; 11(19): 6772 - 6779.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Lamszus, M. A. Brockmann, C. Eckerich, P. Bohlen, C. May, U. Mangold, R. Fillbrandt, and M. Westphal
Inhibition of Glioblastoma Angiogenesis and Invasion by Combined Treatments Directed Against Vascular Endothelial Growth Factor Receptor-2, Epidermal Growth Factor Receptor, and Vascular Endothelial-Cadherin
Clin. Cancer Res., July 1, 2005; 11(13): 4934 - 4940.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. P. Schneider and K. D. Miller
Angiogenesis of Breast Cancer
J. Clin. Oncol., March 10, 2005; 23(8): 1782 - 1790.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Lefranc, T. Mijatovic, V. Mathieu, S. Rorive, C. Decaestecker, O. Debeir, J. Brotchi, P. Van Ham, I. Salmon, and R. Kiss
Characterization of Gastrin-Induced Proangiogenic Effects In vivo in Orthotopic U373 Experimental Human Glioblastomas and In vitro in Human Umbilical Vein Endothelial Cells
Clin. Cancer Res., December 15, 2004; 10(24): 8250 - 8265.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. P. J. Leenders, B. Kusters, K. Verrijp, C. Maass, P. Wesseling, A. Heerschap, D. Ruiter, A. Ryan, and R. de Waal
Antiangiogenic Therapy of Cerebral Melanoma Metastases Results in Sustained Tumor Progression via Vessel Co-Option
Clin. Cancer Res., September 15, 2004; 10(18): 6222 - 6230.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. L. Rakhmilevich, A. T. Hooper, D. J. Hicklin, and P. M. Sondel
Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti-vascular endothelial growth factor receptor-2 antibody
Mol. Cancer Ther., August 1, 2004; 3(8): 969 - 976.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Bello, V. Lucini, F. Costa, M. Pluderi, C. Giussani, F. Acerbi, G. Carrabba, M. Pannacci, D. Caronzolo, S. Grosso, et al.
Combinatorial Administration of Molecules That Simultaneously Inhibit Angiogenesis and Invasion Leads to Increased Therapeutic Efficacy in Mouse Models of Malignant Glioma
Clin. Cancer Res., July 1, 2004; 10(13): 4527 - 4537.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. O. Schmidt, M. Ziu, G. Carrabba, C. Giussani, L. Bello, Y. Sun, K. Schmidt, M. Albert, P. Mcl. Black, and R. S. Carroll
Antiangiogenic Therapy by Local Intracerebral Microinfusion Improves Treatment Efficiency and Survival in an Orthotopic Human Glioblastoma Model
Clin. Cancer Res., February 15, 2004; 10(4): 1255 - 1262.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. A. Brockmann, A. Papadimitriou, M. Brandt, R. Fillbrandt, M. Westphal, and K. Lamszus
Inhibition of Intracerebral Glioblastoma Growth by Local Treatment with the Scatter Factor/Hepatocyte Growth Factor-Antagonist NK4
Clin. Cancer Res., October 1, 2003; 9(12): 4578 - 4585.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J.-y. Liu, Y.-q. Wei, L. Yang, X. Zhao, L. Tian, J.-m. Hou, T. Niu, F. Liu, Y. Jiang, B. Hu, et al.
Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2
Blood, September 1, 2003; 102(5): 1815 - 1823.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. J. Mahasreshti, M. Kataram, M. H. Wang, C. R. Stockard, W. E. Grizzle, D. Carey, G. P. Siegal, H. J. Haisma, R. D. Alvarez, and D. T. Curiel
Intravenous Delivery of Adenovirus-mediated Soluble FLT-1 Results in Liver Toxicity
Clin. Cancer Res., July 1, 2003; 9(7): 2701 - 2710.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Giese, R. Bjerkvig, M.E. Berens, and M. Westphal
Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment
J. Clin. Oncol., April 15, 2003; 21(8): 1624 - 1636.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Lamszus, U. Ulbricht, J. Matschke, M. A. Brockmann, R. Fillbrandt, and M. Westphal
Levels of Soluble Vascular Endothelial Growth Factor (VEGF) Receptor 1 in Astrocytic Tumors and Its Relation to Malignancy, Vascularity, and VEGF-A
Clin. Cancer Res., April 1, 2003; 9(4): 1399 - 1405.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Ciardiello, R. Caputo, V. Damiano, R. Caputo, T. Troiani, D. Vitagliano, F. Carlomagno, B. M. Veneziani, G. Fontanini, A. R. Bianco, et al.
Antitumor Effects of ZD6474, a Small Molecule Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, with Additional Activity against Epidermal Growth Factor Receptor Tyrosine Kinase
Clin. Cancer Res., April 1, 2003; 9(4): 1546 - 1556.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Izumi, E. di Tomaso, A. Hooper, P. Huang, J. Huber, D. J. Hicklin, D. Fukumura, R. K. Jain, and H. D. Suit
Responses to Antiangiogenesis Treatment of Spontaneous Autochthonous Tumors and Their Isografts
Cancer Res., February 15, 2003; 63(4): 747 - 751.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
K. D. Miller, C. J. Sweeney, and G. W. Sledge
The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic era
Ann. Onc., January 1, 2003; 14(1): 20 - 28.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. S. Kim, A. Serur, J. Huang, C. A. Manley, K. W. McCrudden, J. S. Frischer, S. Z. Soffer, L. Ring, T. New, S. Zabski, et al.
Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma
PNAS, August 20, 2002; 99(17): 11399 - 11404.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. Wick, W. Wick, J. Waltenberger, M. Weller, J. Dichgans, and J. B. Schulz
Neuroprotection by Hypoxic Preconditioning Requires Sequential Activation of Vascular Endothelial Growth Factor Receptor and Akt
J. Neurosci., August 1, 2002; 22(15): 6401 - 6407.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
C. J. Conti
Vascular Endothelial Growth Factor: Regulation in the Mouse Skin Carcinogenesis Model and Use in Antiangiogenesis Cancer Therapy
Oncologist, August 1, 2002; 7(90003): 4 - 11.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
H. M. Fathallah-Shaykh
Darts in the Dark Cure Animal, but Not Human, Brain Tumors
Arch Neurol, May 1, 2002; 59(5): 721 - 724.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.